Acorda Therapeutics (ACOR)

Acorda Therapeutics (ACOR)

Postby winston » Thu Feb 20, 2014 5:40 am

not vested

Acorda Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the identification, development, and commercialization of therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other central nervous system disorders primarily in the United States.

Its products include Ampyra (dalfampridine), a potassium channel blocker to improve walking in patients with MS; and Zanaflex Capsules and Zanaflex tablets (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

The company also markets products for the improvement of walking in adult patients with MS under the Fampyra name internationally.


http://todaysbigstock.com/2014/02/19/ac ... sdaq-acor/
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118522
Joined: Wed May 07, 2008 9:28 am

Return to A to D

Who is online

Users browsing this forum: No registered users and 13 guests